EIK1001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for EIK1001, covering 2025-11-12 to 2026-01-26. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. [Phase 2, Phase 3]